Ligue Pulmonaire Genevoise
13
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Video-observed Therapy for Active Tuberculosis: a Feasibility Study
Role: lead
Systematic Follow-up of Patients Surviving an Episode of Acute Hypercapnic Respiratory Failure in the ICU
Role: lead
COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program
Role: collaborator
Objective Evaluation of the Number of Use Hour of Oxygen Therapy in Patients Receiving Supplemental Oxygen
Role: collaborator
Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients
Role: lead
Patient-ventilator Interactions in Long Term Non-invasive Ventilation: Influence of Back-up Frequency
Role: lead
Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Role: collaborator
Patient-Ventilator Interactions in Chronic Obstructive Pulmonary Diseases (COPD) Under Non-Invasive Ventilation
Role: lead
What do built-in Softwares in Home Ventilators Tell us?
Role: lead
Detection of Latent Tuberculosis in Hemodialysis Patients
Role: collaborator
Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis
Role: collaborator
Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area
Role: collaborator
Efficacy of Average Volume Assured Pressure Support With Bi-Level Pressure Support Nocturnal Ventilation
Role: collaborator
All 13 trials loaded